Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.